255 related articles for article (PubMed ID: 30486276)
21. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
[TBL] [Abstract][Full Text] [Related]
22. Fabrication of Chitosan-coated Mesoporous Silica Nanoparticles Bearing Rosuvastatin as a Drug Delivery System.
Ghahfarokhi MR; Dini G; Movahedi B
Curr Drug Deliv; 2022; 19(1):64-73. PubMed ID: 34151762
[TBL] [Abstract][Full Text] [Related]
23. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
He Y; Luo L; Liang S; Long M; Xu H
J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
[TBL] [Abstract][Full Text] [Related]
24. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
[TBL] [Abstract][Full Text] [Related]
25. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
[TBL] [Abstract][Full Text] [Related]
26. Galactosylated Chitosan Modified Magnetic Mesoporous Silica Nanoparticles Loaded with Nedaplatin for the Targeted Chemo-Photothermal Synergistic Therapy of Cancer.
Kong Y; Li X; Liu X; Pang J; Mu X; Liu W
J Nanosci Nanotechnol; 2021 Sep; 21(9):4553-4564. PubMed ID: 33691833
[TBL] [Abstract][Full Text] [Related]
27. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
[TBL] [Abstract][Full Text] [Related]
28. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
29. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
[TBL] [Abstract][Full Text] [Related]
30. Cancer-Cell-Specific Nuclear-Targeted Drug Delivery by Dual-Ligand-Modified Mesoporous Silica Nanoparticles.
Xiong L; Du X; Kleitz F; Qiao SZ
Small; 2015 Nov; 11(44):5919-26. PubMed ID: 26426251
[TBL] [Abstract][Full Text] [Related]
31. Decapeptide functionalized targeted mesoporous silica nanoparticles with doxorubicin exhibit enhanced apoptotic effect in breast and prostate cancer cells.
Tambe P; Kumar P; Paknikar KM; Gajbhiye V
Int J Nanomedicine; 2018; 13():7669-7680. PubMed ID: 30538451
[TBL] [Abstract][Full Text] [Related]
32. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
33. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.
Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X
Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582
[TBL] [Abstract][Full Text] [Related]
34. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
Lv Y; Li J; Chen H; Bai Y; Zhang L
Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
[TBL] [Abstract][Full Text] [Related]
35. Chitosan mediated 5-Fluorouracil functionalized silica nanoparticle from rice husk for anticancer activity.
Dhinasekaran D; Raj R; Rajendran AR; Purushothaman B; Subramanian B; Prakasarao A; Singaravelu G
Int J Biol Macromol; 2020 Aug; 156():969-980. PubMed ID: 32320807
[TBL] [Abstract][Full Text] [Related]
36. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
37. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
Xie Z; Gong H; Liu M; Zhu H; Sun H
J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
[TBL] [Abstract][Full Text] [Related]
38. PEGylated mesoporous silica core-shell redox-responsive nanoparticles for delivering paclitaxel to breast cancer cells.
Shahbaz S; Esmaeili M; Fathian Nasab MH; Imani Z; Bafkary R; Amini M; Atyabi F; Dinarvand R
Int J Pharm; 2024 Apr; 655():124024. PubMed ID: 38537920
[TBL] [Abstract][Full Text] [Related]
39. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
[TBL] [Abstract][Full Text] [Related]
40. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]